Maryknoll P. Linscott

Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation

C. Abendroth, H. Markus, N. Yee, 2023, Biomedicines.